ReviewNutrients2025
Supporting Neurologic Health with Mushroom Nutrition.
Review in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bioactive Coatings with Antimicrobial Activity fromMolecules (Basel, Switzerland) · 2026Review
- Characterization of Children with Intellectual Disabilities and Relevance of MushroomNutrients · 2026Article
- Article
- Edible mushrooms as emerging biofactories for natural therapeutics and oral biopharmaceutical delivery.Frontiers in fungal biology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the extensive types of etiologies and risks causing over 600 types of mental health issues, to convene adequate recommendations in primary care is a difficult assignment. The starting point for preventive interventions on neurologic disorders involves scrutinizing the risk factors while targeting multiple hazards in order to increase the success of an early precautionary mediation plan of action. The primary risk factor for most neurodegenerative diseases is the increasing worldwide median age, although one in seven youngsters also experience a mental disability, namely depression, representing a decline in well-being and conferring a considerable global public health challenge. The brain operates optimally when supported by a holistic approach engaging several aspects, and diet is becoming an integral part of care strategies. Treatment is presently dominated by pharmacotherapy, but additional strategies are needed to prevent and treat mental disorders. Dietary modification can prove to be a cost-effective strategy for the prevention and, in certain conditions, treatment of neurological disorders. Molecules of dietary ingredients, micronutrients, phytonutrients, and additives may modulate depression associated biomarkers. Nutritional exposure during the early developmental stages and maternal impact, lifestyles, and the modulation of the gut microbiota through diet as novel therapies for the treatment of various neuropsychiatric conditions is gaining interest for maintaining brain health. Bioactive substances present in different mushroom species have been ascribed to both direct and indirect mechanisms of influence on neurobehavior, and here we support the recognition of mushroom nutrition as an influential dietary element in prevention and management of some neurologic concerns. Scientific evidence demonstrating the unequivocal link between nutritional mushrooms and cognitive health is only beginning to emerge, and nutritional medicine should be considered as an integral part of mental care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.